BC Cancer Consortium leadership and members share updates with the Network
![](/images/default-source/pagebanners/cancer-biology.tmb-0.jpg?Culture=en&sfvrsn=ff8a8c1c_4)
On Thursday, June 27th, leadership and researchers from the BC Cancer Consortium presented their work to Network members as part of the MOHCCN seminar series.
This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network.
This event was co-chaired by Rosilene Kraft, PhD, PEng, MOHCCN Patient Working Group member, and Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.
Watch the full video
Speakers
BC2C CONSORTIUM ACTIVITIES UPDATE
Dr. Daniel Renouf - Medical Oncologist and Executive Medical Director, BC Cancer - Vancouver; Associate Professor, Faculty of Medicine, UBC; MOHCCN consortium lead (BC2C)
RESEARCH PRESENTATIONS
Multimode whole genome approaches to plasma-based disease monitoring in triple-negative breast cancer
Dr. Samuel Aparicio - Professor, Department of Pathology and Laboratory Medicine, UBC; Head, Department of Breast and Molecular Oncology, BC Cancer Research Institute; MOHCCN cohort lead
Synovial sarcoma chromatin dynamics reveal a continuum in SS18::SSX reprogramming
Kiera Lee - MD/PhD Candidate, Department of Microbiology and Immunology, Michael Smith Laboratories, UBC
Related Team Members
-
Martin
Project LeaderWorking Group Member
Hirst -
Samuel
Project LeaderWorking Group Member
Aparicio -
Daniel
MOHCCN Steering CommitteeConsortium LeaderWorking Group Member
Renouf -
Kiera
Researcher
Lee
Projects
-
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
Related News
-
New study explores patient preferences and concerns to improve data sharing for precision oncology across Canada
A team of health researchers that includes MOHCCN members conducted focus groups with individuals with lived and living experience with cancer to understand their values, expectations, and concerns fo... -
New hope for pancreatic cancer treatments [EXTERNAL MEDIA]
(Globe and Mail, June 21, 2024) Marathon of Hope Cancer Centres Network supports clinical trial to increase personalized treatment based on an individual’s cancer genetics -
Marathon of Hope – Québec consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
Collecting the data needed to move precision medicine forward
In a study published in the journal Value in Health in 2022, a team of health researchers that includes Marathon of Hope Cancer Centres Network (MOHCCN) members proposed a set of 68 core data elements...